» Authors » Hoda T Hammad

Hoda T Hammad

Explore the profile of Hoda T Hammad including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 414
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Christensen C, Chang J, Rostron B, Hammad H, van Bemmel D, Del Valle-Pinero A, et al.
Cancer Epidemiol Biomarkers Prev . 2025 Jan; 34(1):207. PMID: 39780619
No abstract available.
2.
Edwards K, Halenar M, Delnevo C, Villanti A, Bansal-Travers M, OConnor R, et al.
Nicotine Tob Res . 2023 Jul; 25(Suppl_1):S5-S15. PMID: 37506243
Introduction: Understanding the characteristics of premium cigar use patterns is essential for minimizing public health harms. Typically, premium cigars are handmade, larger, more expensive, and without the characterizing flavors that...
3.
Mahoney M, Rivard C, Kimmel H, Hammad H, Sharma E, Halenar M, et al.
Int J Environ Res Public Health . 2022 Apr; 19(7). PMID: 35409819
Background: Prior studies have not clearly established risk of cardiovascular disease (CVD) among smokers who switch to exclusive use of electronic nicotine delivery systems (ENDS). We compared cardiovascular disease incidence...
4.
Anic G, Rostron B, Hammad H, van Bemmel D, Del Valle-Pinero A, Christensen C, et al.
Int J Environ Res Public Health . 2022 Feb; 19(3). PMID: 35162490
Limited data are available for how biomarkers of tobacco exposure (BOE) change when cigarette smokers transition to using electronic nicotine delivery systems (ENDS). Using biomarker data from Waves 1 (2013-2014)...
5.
Mahoney M, Rivard C, Hammad H, Blanco C, Sargent J, Kimmel H, et al.
Int J Environ Res Public Health . 2021 Jul; 18(14). PMID: 34300159
Background: Cardiovascular disease is a key health condition associated with tobacco use; however, clinical measures are not typically possible in population-based studies. In this paper, we assess the reliability and...
6.
Christensen C, Chang J, Rostron B, Hammad H, van Bemmel D, Del Valle-Pinero A, et al.
Cancer Epidemiol Biomarkers Prev . 2021 Jul; 30(10):1947-1955. PMID: 34289969
Background: Former smokers who currently use e-cigarettes have lower concentrations of biomarkers of tobacco toxicant exposure than current smokers. It is unclear whether tobacco toxicant exposure reductions may lead to...
7.
Chang J, Vivar J, Tam J, Hammad H, Christensen C, van Bemmel D, et al.
Cancer Epidemiol Biomarkers Prev . 2021 May; 30(7):1320-1327. PMID: 33947655
Background: While smokeless tobacco (ST) causes oral cancer and is associated with cardiovascular diseases, less is known about how its effects differ from other tobacco use. Biomarkers of potential harm...
8.
Pearson J, Sharma E, Rui N, Halenar M, Johnson A, Cummings K, et al.
JAMA Netw Open . 2020 Nov; 3(11):e2015893. PMID: 33231634
Importance: The prevalence of electronic nicotine delivery systems (ENDS) use, including e-cigarettes, among US young adults (YAs) has raised questions about how these products may affect future tobacco and nicotine...
9.
Alexander J, Liu S, Cullen K, Xiao H, Hammad H, Silveira M, et al.
J Adolesc Health . 2020 Aug; 68(3):612-614. PMID: 32753342
Purpose: This study examined U.S. middle and high school student observations of electronic nicotine product (ENP) use in and around the school building and students' normative perceptions of use among...
10.
Kasza K, Edwards K, Tang Z, Stanton C, Sharma E, Halenar M, et al.
Tob Control . 2020 Apr; 29(Suppl 3):s203-s215. PMID: 32321854
Objective: To report on demographic and tobacco use correlates of cessation behaviours across tobacco products (cigarettes, electronic nicotine delivery systems (ENDS), cigars, hookah and smokeless tobacco) among the US population....